# Przemysław Kotyla

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/przemys-aw-kotyla/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,095 |
| Field | Systemic Sclerosis and Related Diseases |
| h-index | 17 |
| i10-index | 27 |
| Last Known Institution | Medical University of Silesia |
| OpenAlex ID | https://openalex.org/A5034608645 |
| ORCID iD | 0000-0001-8376-6527 |
| Works | 142 |

## Researcher papers

- [Vitamin D status in patients with systemic lupus erythematosus (SLE): A systematic review and meta-analysis](https://scholariq.org/papers/vitamin-d-status-in-patients-with-systemic-lupus-erythematosus-sle-a-systematic/)
- [Immunomodulatory Effects of Diet and Nutrients in Systemic Lupus Erythematosus (SLE): A Systematic Review](https://scholariq.org/papers/immunomodulatory-effects-of-diet-and-nutrients-in-systemic-lupus-erythematosus/)
- [Thromboembolic Adverse Drug Reactions in Janus Kinase (JAK) Inhibitors: Does the Inhibitor Specificity Play a Role?](https://scholariq.org/papers/thromboembolic-adverse-drug-reactions-in-janus-kinase-jak-inhibitors-does-the/)
- [Infliximab Treatment Increases Left Ventricular Ejection Fraction in Patients with Rheumatoid Arthritis: Assessment of Heart Function by Echocardiography, Endothelin 1, Interleukin 6, and NT-pro Brain Natriuretic Peptide](https://scholariq.org/papers/infliximab-treatment-increases-left-ventricular-ejection-fraction-in-patients/)
- [Clinical Aspects of Janus Kinase (JAK) Inhibitors in the Cardiovascular System in Patients with Rheumatoid Arthritis](https://scholariq.org/papers/clinical-aspects-of-janus-kinase-jak-inhibitors-in-the-cardiovascular-system-in/)
- [Are Janus Kinase Inhibitors Superior over Classic Biologic Agents in RA Patients?](https://scholariq.org/papers/are-janus-kinase-inhibitors-superior-over-classic-biologic-agents-in-ra-patients/)
- [Understanding Ocular Findings and Manifestations of Systemic Lupus Erythematosus: Update Review of the Literature](https://scholariq.org/papers/understanding-ocular-findings-and-manifestations-of-systemic-lupus-erythematosus/)
- [Bimodal Function of Anti-TNF Treatment: Shall We Be Concerned about Anti-TNF Treatment in Patients with Rheumatoid Arthritis and Heart Failure?](https://scholariq.org/papers/bimodal-function-of-anti-tnf-treatment-shall-we-be-concerned-about-anti-tnf/)
- [Prevalence of antiphospholipid antibodies in Behçet's disease: A systematic review and meta-analysis](https://scholariq.org/papers/prevalence-of-antiphospholipid-antibodies-in-behcet-s-disease-a-systematic/)
- [Dercum’s disease (adiposis dolorosa): a review of clinical presentation and management](https://scholariq.org/papers/dercum-s-disease-adiposis-dolorosa-a-review-of-clinical-presentation-and/)
- [Psychological Implications to the Therapy of Systemic Lupus Erythematosus](https://scholariq.org/papers/psychological-implications-to-the-therapy-of-systemic-lupus-erythematosus/)

## Researcher topics

- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Inflammatory Myopathies and Dermatomyositis](https://scholariq.org/topics/inflammatory-myopathies-and-dermatomyositis/)
- [Cytokine Signaling Pathways and Interactions](https://scholariq.org/topics/cytokine-signaling-pathways-and-interactions/)

## Researcher university

- [Medical University of Silesia](https://scholariq.org/institutions/medical-university-of-silesia/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.